Current stage -Stage I Page 3 Posts on Medivizor
Navigation Menu

Current stage -Stage I Posts on Medivizor

Different radiation therapy schedules: Hyopfractioned EBRT is as effective as standard EBRT

Posted by on Oct 3, 2016 in Prostate cancer | 0 comments

In a nutshell This study compared the safety and effectiveness of external beam radiation therapy (EBRT) and hypofractioned EBRT (H-EBRT) for localized prostate cancer. Researchers reported no differences in survival or disease recurrence rates between high H-EBRT and EBRT. Some background Radiation therapy is a common treatment for localized...

Read More

The effect of diet and lifestyle in prostate cancer progression and mortality

Posted by on Sep 26, 2016 in Prostate cancer | 0 comments

In a nutshell The main objective of this review was to summarize evidence on the effect of lifestyle and diet on prostate cancer progression, recurrence and death. The authors concluded that a variety of factors appeared to affect prostate cancer progression, including not smoking, exercise and healthy body weight. Some background Prostate...

Read More

Improvement of urinary tract symptoms in patients who underwent robot-assisted prostate surgery

Posted by on Sep 26, 2016 in Prostate cancer | 0 comments

In a nutshell The main aim of this study was to assess urinary tract symptoms (LUTS) in prostate cancer patients following robotic-assisted laparoscopic prostatectomy (RALP). The authors concluded that the majority of patients with moderate to severe LUTS improved significantly following RALP. Some background RALP is a relatively new...

Read More

Focal prostate radiotherapy in early prostate cancer

Posted by on Sep 19, 2016 in Prostate cancer | 0 comments

In a nutshell The main objective of this study was to review all data available on focal radiotherapy (FRT) for men with early prostate cancer. The authors concluded that FRT was an option in early prostate cancer but may not be as effective in intermediate-risk tumors. Some background Radiation therapy is an important part of prostate cancer...

Read More

Hormone therapy may shorten survival in African American men with low- or intermediate-risk prostate cancer

Posted by on Aug 13, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the effect of ethnicity on health outcomes with androgen deprivation therapy (ADT). Researchers reported shorter survival among African American men receiving ADT for low- or intermediate-risk prostate cancer compared to men of other ethnicities. Some background ADT is a type of hormone therapy used to treat...

Read More

The effect of combined radiation and hormone therapy on long-term fatigue

Posted by on Jul 18, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the effect of combined radiation and hormone therapy on long-term fatigue. Researchers reported severe fatigue during and up to 4 years after treatment. Men with increased cancer markers and symptoms were more likely to report higher fatigue levels. Some background Radiation therapy and hormone therapy are often...

Read More

Hyopfractioned or standard external beam radiation therapy – which is better?

Posted by on Jul 11, 2016 in Prostate cancer | 0 comments

In a nutshell This study compared external beam radiation therapy (EBRT) and hypofractioned EBRT (H-EBRT) for low-risk localized prostate cancer. Researchers reported no differences in disease progression or survival. However, an increase in side effects was observed with H-EBRT. Some background Radiation therapy is a common treatment for...

Read More

Different doses and combinations of external beam radiation therapy examined

Posted by on Jun 17, 2016 in Prostate cancer | 0 comments

In a nutshell This study compared different external beam radiation therapy (EBRT) approaches for localized prostate cancer. Authors reported high effectiveness with higher doses of radiation therapy, particularly when hormone therapy was added to treatment. However, these combinations were also associated with the highest rate of side effects. Some...

Read More